B
Novartis AG NVS
$112.14 $0.970.87% NYSE
Recommendation
Prev Close
$112.14
Volume
2,213,618
Avg Vol (90D)
2,138,363
Market Cap
$212.12B
Dividend & Yield
$2.60(2.32%)
52-Week Range
$96.06 - $120.92
P/E (TTM)
19.07
EPS (TTM)
$5.88
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Momentum Stocks That Could Soar Post-Market Volatility
4/21/2025 - MarketBeat
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys?
4/26/2025 - Fool.com Headlines
Kepler Capital Keeps Their Buy Rating on Novartis AG (NOVN)
4/26/2025 - TipRanks Financial Blog
Knightsbridge Asset Management LLC Buys 457 Shares of Novartis AG (NYSE:NVS)
4/25/2025 - Ticker Report
Hayek Kallen Investment Management Trims Stake in Novartis AG (NYSE:NVS)
4/25/2025 - Ticker Report
MML Investors Services LLC Buys 19,331 Shares of Novartis AG (NYSE:NVS)
4/25/2025 - MarketBeat
Marshall Wace LLP Makes New $8.63 Million Investment in Novartis AG (NYSE:NVS)
4/25/2025 - MarketBeat
Harrow and Nordic Pharma to launch generic version of Novartis' Maxitrol
4/24/2025 - Seeking Alpha - Healthcare
Harrow and Nordic Pharma to launch generic version of Novartis' Maxitrol
4/24/2025 - SeekingAlpha.com: All News
MGO One Seven LLC Grows Stock Holdings in Novartis AG (NYSE:NVS)
4/24/2025 - Ticker Report
Swiss And French Pharma Giants Novartis And Sanofi Call For EU Drug Price Hike
4/23/2025 - MENAFN.com
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
4/23/2025 - Zacks Investment Research
Bill Gates' 10 Stock Positions with Huge Upside Potential
4/23/2025 - Insider Monkey
Incyte Gears Up to Report Q1 Earnings: Here's What You Should Know
4/23/2025 - Zacks Investment Research
sanofi novartis ceos press higher drug prices europe trump weighs international reference
4/23/2025 - FiercePharma
Novartis AG (NYSE:NVS) Shares Sold by Kayne Anderson Rudnick Investment Management LLC
4/23/2025 - Ticker Report
Pharma bosses call for higher drug prices in EU to counter tariff threat
4/23/2025 - ireland.com: Business
Pharma bosses call for higher drug prices in EU to counter tariff threat
4/23/2025 - FT.com - World
Swiss Pharma Giant Roche To Invest $50B in US Amid Tariff Threat
4/22/2025 - Investopedia Headlines
Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
4/22/2025 - Fortune
Seaview Investment Managers LLC Has $9.47 Million Holdings in Novartis AG (NYSE:NVS)
4/22/2025 - MarketBeat
Commerce Bank Reduces Holdings in Novartis AG (NYSE:NVS)
4/22/2025 - Ticker Report
Novartis AG (NYSE:NVS) Stock Holdings Cut by Guggenheim Capital LLC
4/22/2025 - Ticker Report
Pharma giant Roche pledges $50 billion US investment in R&D, manufacturing
4/22/2025 - Invezz News
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug
4/22/2025 - Stocktwits News Feed
Income Statement
Total Revenue (TTM)
$51.72B
EBITDA (TTM)
$19.84B
EBIT (TTM)
$16.50B
Net Income (TTM)
$11.94B
Balance Sheet
Total Assets (Q)
$102.25B
Total Debt (Q)
$31.40B
Total Liabilities (Q)
$58.12B
Book Value Per Share (Q)
$22.30
Cash Flow
Cash from Operations (TTM)
$17.62B
Cash from Investing (TTM)
-$7.51B
Cash from Financing (TTM)
-$11.74B
Net Change in Cash (TTM)
-$1.93B
Filings
Filing Date
Friday, January 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
0.24
7-Day Total Return
2.34%
30-Day Total Return
2.82%
60-Day Total Return
9.61%
90-Day Total Return
16.73%
Year to Date Total Return
18.20%
1-Year Total Return
17.83%
2-Year Total Return
21.20%
3-Year Total Return
43.62%
5-Year Total Return
49.96%
52-week Low
Dec 20, 2024 - $96.06
52-week High
Aug 30, 2024 - $120.92
Valuation
Market Cap
$212.12B - Mega Cap
Enterprise Value
$231.97B
Price/Sales (TTM)
4.34
Price/Book (Q)
5.03
Dividends and Shares
Shares Outstanding
2.00B
Dividend Per Share (Most Recent)
$2.60
Dividend Per Share (TTM)
$2.60
Corporate Info
Website
www.novartis.com
Phone Number
41 61 324 11 11
Address
Lichtstrasse 35
Basel, 4056
Country
Switzerland
Year Founded
1996
Business Description
Sector
--
Industry
--
Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an... more
NYSE 04/25/2025 4:00PM Eastern Quotes delayed